Promotional price valid on web orders only. Your contract pricing may differ. Interested in signing up for a dedicated account number?
Learn More
Learn More
Invitrogen™ alpha Amylase 1 Polyclonal Antibody
Rabbit Polyclonal Antibody
Supplier: Invitrogen™ PA589129
Description
Immunogen sequence: QYSSNTQQGR TSIVHLFEWR WVDIALECER YLAPKGFGGV QVSPPNENVA IHNPFRPWWE RYQPVSYKLC TRSGNEDEFR NMVTRCNNVG VRIYVDAVIN HMCGNAVSAG TSSTCGSYFN PGSRDFPAVP YSGWDFNDGK CKTGSGDIEN YNDATQVRDC RLSGLLDLAL GKDYVRSKIA EYMNH; Positive Samples: Mouse liver.
Amylase is an enzyme that catalyses the breakdown of starch into sugars. Amylase is present in human saliva, where it begins the chemical process of digestion. By in situ hybridization combined with high resolution cytogenetics, the amylase gene is mapped to 1p21. Amylase enzymes find use in bread making and to break down complex sugars such as starch (found in flour) into simple sugars. Yeast then feeds on these simple sugars and converts it into the waste products of alcohol and CO2.
Specifications
alpha Amylase 1 | |
Polyclonal | |
Unconjugated | |
Amy1 | |
1,4-alpha-D-glucan glucanohydrolase 1; alpha amylase 1; alpha-amylase 1; Amy1; Amy-1; Amy1a; Amy-1-a; AMY1B; AMY1C; AMY2A; amylase 1, salivary; amylase, alpha 1A (salivary); amylase, salivary, alpha-1A; C030014B17Rik; glycogenase; PA; salivary alpha-amylase; salivary amylase; salivary amylase alpha 1A; salivary and hepatic alpha-amylase | |
Rabbit | |
Affinity Chromatography | |
RUO | |
11722 | |
-20°C, Avoid Freeze/Thaw Cycles | |
Liquid |
ELISA, Western Blot | |
1.71 mg/mL | |
PBS with 50% glycerol and 0.02% sodium azide; pH 7.3 | |
P00687 | |
Amy1 | |
Recombinant fusion protein containing a sequence corresponding to amino acids 16-200 of human AMY1A (NP_0040292). | |
100 μL | |
Primary | |
Mouse | |
Antibody | |
IgG |
Safety and Handling
WARNING: Cancer - www.P65Warnings.ca.gov
Product Content Correction
Your input is important to us. Please complete this form to provide feedback related to the content on this product.
Product Title
Spot an opportunity for improvement?Share a Content Correction